Speaker(s): 

Yves A. Lussier, MD, FAMIA, FACMI, FIAHSI, University of Utah School of Medicine - has nothing to disclose.

Moderator(s): 

Bruce Levy, MD, Staff, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• contrast the limitations of traditional case-control methodologies with the advantages provided by N-of-1 omics approaches in rare diseases and precision medicine.
• identify specific analytical strategies - such as inter-N-of-1, personalome, and N-of-1 pathway-based methods - and describe their roles in enhancing statistical power and biomarker discovery
• appraise practical strategies required for effectively integrating single-subject analytics into clinical research and learning health systems.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Bruce Levy, MD, Dean Parry, RPh, Trang Dang, MD, and Amanda Staskiel, RN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None